Benjamin Cuer
@bcuer.bsky.social
Reposted by Benjamin Cuer
Long-term sequelae in Ebola virus disease survivors receiving anti-Ebola therapies in the Democratic Republic of Congo: A prospective cohort study
✅ Just Accepted
⭐ Editor's Choice
#IDSky
✅ Just Accepted
⭐ Editor's Choice
#IDSky
Long-term sequelae in Ebola virus disease survivors receiving anti-Ebola therapies in the Democratic Republic of Congo: A prospective cohort study
The 2018–2020 Ebola outbreak in the Democratic Republic of Congo (DRC) marked the first major cohort of Ebola survivors treated with advanced therapeutics, including monoclonal antibodies (REGN-EB3, Ansuvimab, ZMapp) and Remdesivir.
doi.org
August 6, 2025 at 2:33 PM
Long-term sequelae in Ebola virus disease survivors receiving anti-Ebola therapies in the Democratic Republic of Congo: A prospective cohort study
✅ Just Accepted
⭐ Editor's Choice
#IDSky
✅ Just Accepted
⭐ Editor's Choice
#IDSky